IM Cannabis Imports 400 Kilos Of Premium Indoor-Grown Dried Cannabis From Canada To Israel
IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) announced on Wednesday that Focus Medical Herbs Ltd.
IM Cannabis To Buy Jerusalem-Based Medical Marijuana Pharmacy For $4.9M In Cash And Stock
IM Cannabis Corp. (CSE: IMCC), (NASDAQ: IMCC) will acquire the majority of Jerusalem’s leading medical cannabis pharmacy, Oranim. The cannabis company confirmed Wednesday that its Israeli subsidiary IMC Holdings Ltd.
IM Cannabis Q3 Revenue Grows 30% Sequentially To $11.5M
IM Cannabis (NASDAQ: IMCC) (CSE: IMCC) announced its unaudited financial results on Monday for the three and nine-month periods ended September 30, 2021, with revenues of CA$14.4 million ($11.5 million), a sequential increase of approximately 30%.
70 Biggest Movers From Friday
Gainers
Everspin Technologies, Inc. (NASDAQ: MRAM) shares surged 63.2% to close at $10.74 on Friday after the company reported better-than-expected Q3 results and issued Q4 sales guidance above estimates.
VA Rejects Cannabis Research As Veterans Plead For Medical Cannabis
The VA will not expand its cannabis research, despite recent bipartisan calls from Congress, doctors and veterans.
Stock Wars: Cronos Group Vs. cbdMD
Benzinga’s weekly Stock Wars matches up two leaders in a major industry sector with the goal of determining which company is the better investment.
Roth Capital Initiates Coverage On IM Cannabis with Buy Rating, Announces Price Target of $8
Roth Capital analyst Scott Fortune initiates coverage on IM Cannabis (NASDAQ:IMCC) with a Buy rating and announces Price Target of $8.